| ANADYS PHARMA (ANDS) |
|
|
| NASDAQ:ANDS |
Last Trade: Today @ 5:20:00 PM |
| Last Price: 1.99 |
Change: ($-0.02 -0.9951%) |
| Open: |
1.99 |
Prev. Close: |
2.01 |
| Day's High: |
2.15 |
Low: |
1.96 |
| 52-Week High: |
4.90 |
52-Week Low: |
1.36 |
| Bid: |
2.01 / 100 |
Ask: |
2.02 / 500 |
| Volume: |
267,120 |
Outstanding: |
28,651,106 |
| Market cap: |
$46 M
|
|
|
|
|
| Anadys Pharmaceuticals is a biopharmaceutical company that discovers, develops and commercializes small-molecule medicines for the treatment of hepatitis and cancer. As of Dec 31 2006, Co.'s clinical development programs include: ANA975 , an oral prodrug of isatoribine for the treatment of hepatitis C virus (HCV) and hepatitis B virus (HBV), which it is co-developing with Novartis International Pharmaceutical Ltd.; ANA380 for the treatment of HBV, which it is co-developing with LG Life Sciences; ANA773 , an oral TLR-7 prodrug agonist for the treatment of certain cancers; and AN 025-1 , a series of non-nucleoside NS5B polymerase inhibitors, for the treatment of chronic HCV infection. |
ANADYS PHARMA Press ReleasesAnadys Pharmaceuticals to Present at the ROTH OC Growth Stock Conference - Tuesday, March 09, 2010
/C O R R E C T I O N -- Anadys Pharmaceuticals, Inc./ - Thursday, February 25, 2010
WallstreetStockReview.com - AirStar assists in getting a Certificate of Authorization (COA) for the - Saturday, January 23, 2010
GELV Stocks Surge - Friday, December 18, 2009
Biotechnology Stocks Top Losers were CTIC, ANDS, SQNM : by PennyStockPickalert.com - Friday, December 18, 2009
Anadys Pharmaceuticals to present at the JMP Securities Healthcare Focus Conference - Monday, September 28, 2009
Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences - Thursday, September 03, 2009
Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results - Friday, April 17, 2009
Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry - Thursday, March 26, 2009
Anadys Pharmaceuticals to Present at the Citi Biotech Day - Thursday, March 26, 2009
Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference - Thursday, March 12, 2009
Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2008 Financial Results - Thursday, February 19, 2009
Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference - Monday, February 02, 2009
ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infecti - Monday, December 01, 2008
Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference - Tuesday, November 25, 2008
Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference - Thursday, November 13, 2008
Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference - Wednesday, November 05, 2008
Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healt - Saturday, November 01, 2008
Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study - Tuesday, October 28, 2008
Anadys Pharmaceuticals to Present at Bio Investor Forum - Monday, October 27, 2008
Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights - Friday, October 24, 2008
Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008 - Monday, October 20, 2008
Anadys Pharmaceuticals to Report Third Quarter 2008 Financial Results - Thursday, October 16, 2008
Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference - Tuesday, September 30, 2008
Anadys Pharmaceuticals to Present at The Merriman Curhan Ford Investor Summit - Tuesday, September 09, 2008
Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference - Saturday, August 02, 2008
Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV - Tuesday, July 08, 2008
Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences - Tuesday, May 13, 2008
Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results - Thursday, April 24, 2008
Get this stock quote and other market data from XML Stock Quotes.com
|
